Botulinum Toxin Injection versus Extraocular Muscle Surgery for Acute Acquired Comitant Esotropia
Sirinya Suwannaraj,Chawisa Rojanasaksothron,Yanasiri Methapisittikul,Phanthipha Wongwai,Yosanan Yospaiboon
DOI: https://doi.org/10.2147/OPTH.S401019
2023-01-31
Clinical Ophthalmology
Abstract:Sirinya Suwannaraj, Chawisa Rojanasaksothron, Yanasiri Methapisittikul, Phanthipha Wongwai, Yosanan Yospaiboon KKU Eye Center, Department of Ophthalmology, Faculty of Medicine, Khon Kaen University, Khon Kaen, Thailand Correspondence: Yosanan Yospaiboon, KKU Eye Center, Department of Ophthalmology, Faculty of Medicine, Khon Kaen University, 123 Mitraparb Highway, Khon Kaen, 40002, Thailand, Tel +66-4336-3010, Fax +66-4334-8383, Email Purpose: To compare the success rate of extraocular muscle surgery and botulinum toxin injection for treatment in patients with acute acquired comitant esotropia (AACE). Patients and Methods: This is a retrospective cohort study in which we treated 34 patients of AACE with botulinum toxin compared with 80 patients who had been treated with surgery. The data included angle of deviation in prism diopter (PD) at baseline and one, three, and six months after treatment. The main outcome was the success rate in each treatment group. Results: In the surgery group, mean esodeviation angles at baseline and one, three, and six months after treatment were 50.8 ± 18.3 PD, 4.9 ± 8.3 PD, 4.6 ± 9.5 PD, and 5.5 ± 10.3 PD, whereas those in the botulinum toxin group were 51.2 ± 14.3 PD, 13.9 ± 17.4 PD, 22.0 ± 19.3, and 31.3 ± 23.8 PD, respectively. There was a statistically significant difference in the deviation angles between the two groups ( p < 0.001). The success rate in the surgery group at one, three, and six months was 81%, 84%, and 79%, whereas that in the botulinum toxin group was 50%, 27%, and 27%. Conclusion: Botulinum toxin injection was not as effective as conventional extraocular muscle surgery in AACE patients. However, the treatment is safe, fast-acting, and improves both cosmetic appearance and quality of life. This may be considered as a chance for patients not preferring surgery. Keywords: botulinum toxin, muscle surgery, acute acquired comitant esotropia Esotropia is a common type of strabismus that mostly occurs after infancy or during childhood, but it could appear in adults or even the elderly. 1,2 Acute acquired comitant esotropia (AACE) is a subtype of esotropia defined by acute onset, the same deviation angle in all directions of gaze, and normal ocular motility. 3 AACE can have various causes such as visual deprivation, refractive error, neurological abnormality, and excessive near work. 3–5 The incidence of AACE appears to have risen in recent years, which may be attributable to increased computer and smartphone use. Moreover, the COVID-19 pandemic has led to more people working and studying online, which may aggravate the condition. 6,7 AACE may reduce the quality of life, causing diplopia, impaired stereopsis, and/or cosmetic, social, and amblyopic problems, the latter of which may lead to poor vision and blindness in children. Currently, choices for treatment include horizontal rectus muscle surgery 2,8 and botulinum toxin injection. 9,11 Due to the increasing number of AACE patients and insufficient hospital resources, the waiting list for surgery can be extremely long. In such cases, botulinum toxin may be employed as an alternative treatment. However, its rate of success remains unclear, as does the duration of its effect. Previous studies have reported botulinum toxin injection as being as effective as conventional rectus muscle surgery. 4,9,13 However, the samples in those studies were too small to draw a definitive conclusion. Based on our personal clinical experience, we hypothesize that botulinum toxin may not be as effective as strabismus surgery and the magnitude of deviation may alter the result of treatment. The aim of this study was, therefore, to compare the success rate of strabismus surgery with that of botulinum toxin injection and compare the results in different magnitude of deviation angle in a larger series of AACE patients. This retrospective cohort study was conducted in accordance with the Declaration of Helsinki and was approved by the Khon Kaen University Ethics Committee for Human Research (HE641629). Medical records of AACE patients who had been treated either by rectus muscle surgery or botulinum toxin injection at the KKU Eye Center, Srinagarind Hospital, Khon Kaen University, Thailand, from January 2014 to October 2021 were comprehensively reviewed. Although patient consent to review their medical records was not required by the ethics committee, the data in case report forms nevertheless had no linkage to the patient identities and the patient data confidentiality was protected. Diagnostic criteria of AACE consisted of acute onset, the same deviation angle in all directions of gaze, and normal ocular motility. Inclusion criteria were patients who met these diagnostic -Abstract Truncated-